Clinical Trial Update: 24-hr Intraocular Pressure Control With Dorzolamide/Timolol vs the Brimonidine/Timolol Fixed Combination [Phase 4]

View source ↗

Summary

Phase 4 trial comparing dorzolamide/timolol versus brimonidine/timolol fixed combinations for 24-hour intraocular pressure control in glaucoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Combigan (brimonidine tartrate and timolol maleate)
• Cosopt (dorzolamide/timolol)

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Glaucoma | Phase 4 | Status: COMPLETED